封面
市場調查報告書
商品編碼
1514140

全球疼痛管理設備市場

Pain Management Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球疼痛管理設備市場預計將達到 50 億美元

全球疼痛管理設備市場預計 2023 年將達到 30 億美元,預計到 2030 年將達到 50 億美元,2023-2030 年分析期間複合年成長率為 7.7%。神經刺激設備是本報告分析的細分市場之一,預計複合年成長率為 8.3%,到分析期結束時將達到 35 億美元。分析期內輸液幫浦產業的複合年成長率預計為 6.5%。

美國市場預估為7.733億美元,中國預期複合年成長率為11.6%

預計 2023 年美國疼痛管理設備市場規模將達 7.733 億美元。中國作為世界第二大經濟體,預計到 2030 年市場規模將達到 12 億美元,2023-2030 年分析期間複合年成長率為 11.6%。其他值得注意的區域市場包括日本和加拿大,在分析期間預計複合年成長率分別為 3.7% 和 6.9%。在歐洲,德國的複合年成長率預計為 4.6%。

全球疼痛管理設備市場—主要趨勢和促進因素總結

疼痛管理設備正在成為解決慢性疼痛的重要組成部分,慢性疼痛是一種複雜且持久的疾病,對傳統醫療方法提出了挑戰。從脊髓刺激設備和鞘內泵等侵入性植入到 TENS 裝置和行動應用程式等非侵入性工具,這些設備為安全且不成癮的治療開闢了新途徑。這些技術特別有利於疼痛管理,例如慢性手術後腰痛,還可以透過直接靶向疼痛受體或改變疼痛訊號途徑來顯著減少對藥物的需求。周邊神經刺激等創新和虛擬實境等非侵入性技術進一步使治療領域多樣化,既可以緩解疼痛,又不會產生傳統疼痛管理方法常見的全身性副作用。

由於幾個提高其採用率和有效性的關鍵因素,疼痛管理設備市場正在擴大。設備技術的進步不斷進一步完善這些工具的功能和易用性,整合無線連接和智慧型手機整合等尖端功能。這些技術進步與人們日益認知到慢性疼痛是一個重要的公共衛生問題以及對創新和有效管理策略的需求不斷成長相一致。此外,世界人口老化和持續的鴉片危機凸顯了需要替代療法來解決疼痛而又避免成癮風險,從而推動設備成為首選。這些因素,加上監管政策和保險覆蓋範圍的擴大,推動了疼痛管理設備的取得和依賴。

由於對有效、安全和以患者為中心的治療方法的需求,疼痛管理設備的未來看起來充滿希望。隨著慢性疼痛盛行率的增加,開發提供精確和個人化疼痛緩解的先進技術的重要性也隨之增加。持續的技術創新預計將推動數位工具的整合,以提高患者的參與度和治療依從性。然而,這些設備的有效性必須得到嚴格的臨床研究的支持,以區分真正的治療效果和安慰劑效果。疼痛管理設備的不斷發展不僅反映了技術的進步,而且反映了對疼痛生理學的更深入理解,旨在提供更有針對性和更有效的治療。隨著技術和以患者為中心的策略走在改變現代醫療保健中慢性疼痛管理方式的最前沿,這一領域將大大擴展。

受訪企業舉例(共34家)

  • Baxter International, Inc.
  • Bio-Medical Research(BMR)Ltd.
  • Boston Scientific Corporation
  • Halyard Health, Inc.
  • Stryker Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP-8301

Global Pain Management Devices Market to Reach US$5.0 Billion by 2030

The global market for Pain Management Devices estimated at US$3.0 Billion in the year 2023, is expected to reach US$5.0 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Neurostimulation Devices, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$3.5 Billion by the end of the analysis period. Growth in the Infusion Pumps segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$773.3 Million While China is Forecast to Grow at 11.6% CAGR

The Pain Management Devices market in the U.S. is estimated at US$773.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Pain Management Devices Market - Key Trends and Drivers Summarized

Pain management devices are emerging as a pivotal element in addressing chronic pain, a complex and persistent condition that challenges traditional healthcare approaches. These devices, ranging from invasive implants like spinal cord stimulators and intrathecal pumps to noninvasive tools such as TENS units and mobile applications, offer new avenues for treatment, combining safety with non-addictive properties. Particularly beneficial in managing conditions like chronic back pain post-surgery, these technologies also significantly reduce the need for pharmaceuticals by directly targeting pain receptors or altering pain signal pathways. Innovations such as peripheral nerve stimulation and noninvasive techniques like virtual reality further diversify the treatment landscape, providing relief without the systemic side effects often associated with traditional pain management methods.

The market for pain management devices is expanding, driven by several key factors that enhance their adoption and effectiveness. Advances in device technology continue to refine the functionality and user-friendliness of these tools, integrating cutting-edge features like wireless connectivity and smartphone integration. This technological progression is paralleled by increasing recognition of chronic pain as a significant public health issue, which has elevated demand for innovative and effective management strategies. Furthermore, the aging global population and the ongoing opioid crisis underscore the need for alternative therapies that address pain without the risk of addiction, promoting devices as preferable options. These elements, combined with supportive regulatory policies and broader insurance coverage, facilitate greater access to and reliance on pain management devices.

The future of pain management devices looks promising, fueled by the necessity for effective, safe, and patient-centered treatment modalities. As the prevalence of chronic pain rises, so does the importance of developing advanced technologies that offer precise and personalized pain relief. Continued innovation is expected to drive the integration of digital tools that enhance patient engagement and treatment compliance. However, the effectiveness of these devices must be underpinned by rigorous clinical research to differentiate true therapeutic benefits from placebo effects. The ongoing evolution of pain management devices not only reflects advancements in technology but also a deeper understanding of pain physiology, aiming to provide more targeted and effective treatments. This field is set to expand significantly, with technology and patient-centric strategies at the forefront of transforming how chronic pain is managed in contemporary healthcare.

Select Competitors (Total 34 Featured) -

  • Baxter International, Inc.
  • Bio-Medical Research (BMR) Ltd.
  • Boston Scientific Corporation
  • Halyard Health, Inc.
  • Stryker Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Pain Management Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Strong Market for Home Healthcare Devices Provides the Foundation for Growth
    • Increasing Prevalence of Chronic Pain Conditions Drives Market Growth
    • Technological Innovations in Pain Management Devices Propel Demand
    • Rising Geriatric Population Expands Addressable Market Opportunity
    • Non-invasive Pain Relief Solutions Strengthen Business Case
    • Integration of Wearable Technology in Pain Management Generates Demand
    • Advancements in Neurostimulation Devices Accelerate Market Growth
    • Rise in Sports Injuries and Accidents Drives Adoption of Pain Management Devices
    • Increasing Awareness of Pain Management Solutions. This is How it Impacts the Market
    • E-commerce Platforms Expand Market Reach
    • Personalized Pain Management Devices Spur Customized Healthcare Solutions
    • Development of Portable and User-friendly Devices Strengthens Market Demand
    • Rise in Post-surgical Pain Management Needs Accelerates Market Growth
    • Focus on Improving Patient Quality of Life Drives Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pain Management Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pain Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neuropathic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neuropathic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Neuropathic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cancer Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cancer Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Cancer Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Facial Pain & Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Facial Pain & Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Facial Pain & Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Musculoskeletal Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Musculoskeletal Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Musculoskeletal Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Pain Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Pain Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Pain Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Pain Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION